title: Effects of outdoor air pollutants on platelet activation in people with type 2 diabetes.
abstract: Exposure to air pollution is associated with increased morbidity and mortality from cardiovascular disease. We hypothesized that increases in exposure to ambient air pollution are associated with platelet activation and formation of circulating tissue factor-expressing microparticles. We studied 19 subjects with type 2 diabetes, without clinical evidence of cardiovascular disease, who had previously participated in a human clinical study of exposure to ultrafine particles (UFP). Blood was obtained for measurements of platelet activation following an overnight stay in the Clinical Research Center, prior to each of their two pre-exposure visits. Air pollution and meteorological data, including UFP counts, were analyzed for the 5 days prior to the subjects' arrival at the Clinical Research Center. Contrary to expectations, increases in UFP were associated with decreases in surface expression of platelet activation markers. The number of platelet-leukocyte conjugates decreased by -80 (95% confidence interval (CI) -123 to -37, p = 0.001) on the first lag day (20-44 h prior to the blood draw) and by -85 (CI -139 to -31, p = 0.005) on combined lag days 1 to 5, per interquartile range (IQR) increase in UFP particle number (2482). However, levels of soluble CD40L increased 104 (CI 3 to 205, p = 0.04) pg/ml per IQR increase in UFP on lag day 1, a finding consistent with prior platelet activation. We speculate that, in people with diabetes, exposure to UFP activates circulating platelets within hours of exposure, followed by an increase in soluble CD40L and a rebound reduction in circulating platelet surface markers.
authors.affiliation: University of Rochester Medical Center, Rochester, NY 14642, USA. mark_frampton@urmc.rochester.edu
authors.forename: Mark W
authors.initials: MW
authors.lastname: Frampton
authors.forename: Jan
authors.initials: J
authors.lastname: Bausch
authors.forename: David
authors.initials: D
authors.lastname: Chalupa
authors.forename: Philip K
authors.initials: PK
authors.lastname: Hopke
authors.forename: Erika L
authors.initials: EL
authors.lastname: Little
authors.forename: David
authors.initials: D
authors.lastname: Oakes
authors.forename: Judith C
authors.initials: JC
authors.lastname: Stewart
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Utell
mesh_terms: D000328:Adult; D000393:Air Pollutants / Q000032:analysis / Q000633:toxicity*; D000397:Air Pollution / Q000009:adverse effects; D015415:Biomarkers / Q000097:blood; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D023201:CD40 Ligand / Q000097:blood; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000150:complications; D055252:Cell-Derived Microparticles / Q000187:drug effects / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D015536:Down-Regulation / Q000187:drug effects*; D004781:Environmental Exposure / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010316:Particle Size; D052638:Particulate Matter / Q000032:analysis / Q000633:toxicity; D015539:Platelet Activation / Q000187:drug effects*; D012995:Solubility; D013499:Surface Properties; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D000393:Air Pollutants; D015415:Biomarkers; D052638:Particulate Matter; D023201:CD40 Ligand